KRAS-G12D | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,839 results for “KRAS-G12D”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

QTX3034 in Patients With KRAS G12D Mutation

250 participants · First posted Jan 26, 2024

Active, not recruiting

QTX3046 in Patients With KRAS G12D Mutations

240 participants · First posted May 24, 2024

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

604 participants · First posted Sep 15, 2023

A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation

152 participants · First posted Oct 31, 2024

RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors

30 participants · First posted Aug 9, 2024

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

65 participants · First posted Nov 15, 2024

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

240 participants · First posted Jan 28, 2025

Not yet recruiting

A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors

520 participants · First posted May 9, 2025

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

108 participants · First posted Jan 23, 2024

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

630 participants · First posted Sep 19, 2024

Page 1 of 117